Vendor, Danbury, CT
The National Organization for Rare Disorders Inc.
UEI PCPAHHLS8VB6, CAGE 062L2
1 award and $0 obligated between January 5, 2024 and January 5, 2024, 100% under full and open competition, against 1.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40119C10091Definitive Contract, January 5, 2024, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | The Purpose of This Modification Is to Change the Buyer for Invoicing Purposes. All Other Terms and Conditions Remain Unchanged.NAICS 813212, PSC AN41 | $0 |
- Places of performance
- Connecticut
- Product and service codes
- AN41 Health R&D Services; Health Care - Other; Basic Research
- Transactions
- 1 across 1 awards